Pradžia › LOPSL › South Carolina
LOPSL klinikiniai tyrimai South Carolina
14 tyrimai dėl LOPSL ieško dalyvių vietose South Carolina.
Miestai South Carolina
Oficialus tyrimo tekstas (anglų kalba)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
Renkami dalyviai2 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- ir dar 1
Renkami dalyviai2/3 fazė
Amžius nuo 35 iki 80 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-03 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
Renkami dalyviai3 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-09 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Rock Hill
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2025-10-08 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
Renkami dalyviaiStebimasis tyrimas
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2025-08-05 · NCT06122077Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.